Apyx Medical (NASDAQ:APYX) Trading Up 1.4% – Still a Buy?

Apyx Medical Co. (NASDAQ:APYX) shares shot up 1.4% during trading on Tuesday . The stock traded as high as $1.44 and last traded at $1.44. 30,903 shares changed hands during trading, a decline of 18% from the average session volume of 37,894 shares. The stock had previously closed at $1.42.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Craig Hallum upgraded Apyx Medical to a “strong-buy” rating in a report on Thursday, October 24th. BTIG Research started coverage on shares of Apyx Medical in a research report on Thursday, October 17th. They set a “neutral” rating on the stock.

Apyx Medical Price Performance

The company has a debt-to-equity ratio of 3.03, a current ratio of 5.46 and a quick ratio of 4.52. The stock has a 50 day simple moving average of $1.58 and a two-hundred day simple moving average of $1.36. The company has a market cap of $54.20 million, a price-to-earnings ratio of -1.73 and a beta of 1.26.

Apyx Medical (NASDAQ:APYX) last announced its quarterly earnings data on Friday, November 8th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. Apyx Medical had a negative net margin of 58.59% and a negative return on equity of 137.98%. The firm had revenue of $11.49 million during the quarter, compared to analyst estimates of $11.66 million. During the same quarter in the prior year, the firm posted ($0.13) earnings per share. On average, equities research analysts predict that Apyx Medical Co. will post -0.68 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in APYX. Kingsview Wealth Management LLC raised its position in Apyx Medical by 8.7% in the fourth quarter. Kingsview Wealth Management LLC now owns 135,245 shares of the company’s stock valued at $214,000 after purchasing an additional 10,800 shares during the period. Private Advisor Group LLC raised its holdings in Apyx Medical by 3.9% in the 3rd quarter. Private Advisor Group LLC now owns 322,321 shares of the company’s stock valued at $400,000 after buying an additional 12,180 shares during the period. Finally, Royce & Associates LP lifted its position in Apyx Medical by 3.4% in the third quarter. Royce & Associates LP now owns 2,582,490 shares of the company’s stock valued at $3,202,000 after buying an additional 85,267 shares during the last quarter. 55.33% of the stock is currently owned by institutional investors and hedge funds.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.